LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.60 | 27.76 | 106 | 7045 | 0.0150 | 0.1826 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.60 | 27.76 | 2068 | 7045 | 0.2935 | 0.7155 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.60 | 27.76 | 376 | 7045 | 0.0534 | 0.3858 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 78.60 | 27.76 | 2520 | 7045 | 0.3577 | 0.7584 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.31 | 27.76 | 44 | 6976 | 0.0063 | 0.0595 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.31 | 27.76 | 2080 | 6976 | 0.2982 | 0.7184 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.31 | 27.76 | 142 | 6976 | 0.0204 | 0.2272 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 80.31 | 27.76 | 2546 | 6976 | 0.3650 | 0.7625 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.01 | 27.76 | 22 | 7000 | 0.0031 | -0.0287 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.01 | 27.76 | 2088 | 7000 | 0.2983 | 0.7186 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.01 | 27.76 | 85 | 7000 | 0.0121 | 0.1506 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 82.01 | 27.76 | 2595 | 7000 | 0.3707 | 0.7661 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 83.72 | 27.76 | 17 | 7055 | 0.0024 | -0.0595 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 83.72 | 27.76 | 2095 | 7055 | 0.2969 | 0.7180 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 83.72 | 27.76 | 71 | 7055 | 0.0101 | 0.1247 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 83.72 | 27.76 | 2655 | 7055 | 0.3763 | 0.7697 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 85.42 | 27.76 | 10 | 7025 | 0.0014 | -0.1200 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 85.42 | 27.76 | 2109 | 7025 | 0.3002 | 0.7202 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 85.42 | 27.76 | 58 | 7025 | 0.0083 | 0.0967 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 85.42 | 27.76 | 2656 | 7025 | 0.3780 | 0.7706 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.13 | 27.76 | 22 | 6987 | 0.0031 | -0.0287 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.13 | 27.76 | 2110 | 6987 | 0.3020 | 0.7212 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.13 | 27.76 | 51 | 6987 | 0.0073 | 0.0793 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 87.13 | 27.76 | 2662 | 6987 | 0.3810 | 0.7721 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 88.84 | 27.76 | 18 | 6965 | 0.0026 | -0.0529 | MN20160318_Q01 | E05 |